426 research outputs found

    Role of bi-specific monoclonal antibodies in immunodiagnostic assay

    Get PDF
    This review paper highlights the use of bi-specific monoclonal antibodies (bsMAb) in the diagnostic assays for the early detection of pathogens of human infectious diseases such as severe acute respiratory syndrome (SARS), chikungunya (CHIKV), tuberculosis (TB) and dengue. Bi-specific monoclonal antibodies (bsMAb) are unique and artificially engineered macromolecules with two distinct binding sites, and are capable of binding two different antigens non-covalently. However, the traditional methods of diagnosis such as virus or bacterial isolation, and PCR amplification are quite expensive and time consuming. Bispecific monoclonal antibodies (bsMAb) are versatile, and can increase the specificity and sensitivity of detection in the suspected individuals. Therefore, immunodiagnostic assays using bsMAb are less expensive, and a large number of clinical samples could be analyzed at a faster rate for the detection of pathogens within a stipulated time. This could allow in developing a cost effective diagnostic kit, which is very useful particularly in the developing countries for the early assessment of the disease outbreak

    Dengue Diagnostics: Current Scenario

    Get PDF
    There is an urgent requirement for specific, sensitive and inexpensive dengue diagnostic tools that can be used for clinical management, surveillance and outbreak investigations would permit early intervention to treat patients and prevent or control epidemics. Additionally, new techniques for the early detection of severe disease such as the use of biomarkers have the potential to decrease morbidity and mortality. Recent developments in rapid detection technologies offer the promise of improved diagnostics for case management and the early detection of dengue outbreaks. This short review summarizes the various diagnostics tests currently pursued

    A Mini-review of Dengue Vaccine Development

    Get PDF
    About 100 million dengue cases are reported annually and an estimated 2.5 billion people are susceptible to the infection mostly in the tropical regions. Dengue virus is a member of the Flavivirus genus and consists of four serotypes (DV-1, DV-2, DV-3, and DV- 4), each of which is capable of causing dengue fever and the more severe dengue hemorrhagic fever or dengue shock syndrome. There is an urgent need to develop a safe and effective vaccine that induces protective immune response to all the four serotypes overcoming antibody dependent enhancement. At present there is no licensed vaccine or specific therapeutic measures for prevention or management of the fatal infection. This mini review outlines the different vaccine candidates that are at various stages of development

    Targeting strategies and nanocarriers in vaccines and therapeutics

    Get PDF
    In the past few decades, remarkable advances have been made in the field of immunology and molecular biology. Even though the efficacy level, protein binding capacity and other pharmacological parameters are extraordinary, formulations have become more challenging in terms of making drugs or antigens reach specific sites of action, the release rate of a drug at the site of action, proper presentation of an antigen by antigen-presenting cells or dendritic cells and other pharmacokinetic and pharmacodynamic parameters of finished drug products and vaccines. The purpose of this review is to present a brief overview of the challenges to drug targeting, especially vaccines, as well as of different approaches designed to overcome these barriers

    Subthreshold FIR Filter Architecture for Ultra Low Power Applications

    Full text link

    Modulation of mechanical resonance by chemical potential oscillation in graphene

    Get PDF
    The classical picture of the force on a capacitor assumes a large density of electronic states,such that the electrochemical potential of charges added to the capacitor is given by the external electrostatic potential and the capacitance is determined purely by geometry. Here we consider capacitively driven motion of a nano-mechanical resonator with a low density of states, in which these assumptions can break down. We find three leading-order corrections to the classical picture: the first of is a modulation in the static force due to variation in the internal chemical potential; the second and third are change in static force and dynamic spring constant due to the rate of change of chemical potential, expressed as the quantum (density of states) capacitance. As a demonstration, we study a capacitively driven graphene mechanical resonators, where the chemical potential is modulated independently of the gate voltage using an applied magnetic field to manipulate the energy of electrons residing in discrete Landau levels. In these devices, we observe large periodic frequency shifts consistent with the three corrections to the classical picture. In devices with extremely low strain and disorder, the first correction term dominates and the resonant frequency closely follows the chemical potential. The theoretical model fits the data with only one adjustable parameter representing disorder-broadening of the Landau levels. The underlying electromechanical coupling mechanism is not limited the particular choice of material, geometry, or mechanism for variation in chemical potential, and can thus be extended to other low-dimensional systems.Engineering and Applied Science
    • …
    corecore